COCP - חוב כולל להון Cocrystal Pharma Corp

Cocrystal Pharma, Inc. (COCP) operations are independent of market cycles, as combating infections remains a global priority and share prices are driven by test results. Laboratories are implementing robotic dispensers and data analysis software. Reliable raw material supply chains and contractor diversification support high margins. This chart illustrating the price action of the separate_debt_total_eq metric currently shows a level of 1.33.

Operational efficiency dynamics directly impact the 1.33 calculation model, which measures the degree of business dependence on external borrowings relative to equity. Cocrystal Pharma, Inc. (COCP) minimizes its debt load through a low need for headcount expansion by outsourcing clinical trials, which confirms the stable debt-to-equity ratio shown on this chart.